Category: Moneyball Picks
-
While your Bitcoin and Dogecoin shredded, MARV, GMX, CYBN, GLM, GMTN, and PINK doubled: Diversify, children!
Who’s a boomer now, Dogetards? For a few months there, a legion of newly minted investors, convinced they invented daytrading with their stimulus cheques and chicken tendies, watched their $500 investments run to new heights, taking AMC Cinemas (AMC.Q) to a $28 billion valuation, and driving Bitcoin and Dogecoin to stupid new highs. It was…
-
![Diagnos (ADK.V) uses AI and telemedicine to scan your eye for health issues in 16 countries]()
Diagnos (ADK.V) uses AI and telemedicine to scan your eye for health issues in 16 countries
In a world where companies toss the term ‘artificial intelligence’ around whenever the office intern figures out how to get a spreadsheet pie chart to update automatically, it’s nice to see a company utilizing actual AI and machine learning in a manner that involves actual intelligence and learning. Diagnos (ADK.V) is a health tech deal…
-
Pure Extracts (PULL.C) looks to level up with dealers license application
At a time when many cannabis companies are enjoying bursts of investor interest, management at BC-based extractor Pure Extracts (PULL.C) must be getting frustrated as they roll out new contracts, new manufacturing lines, and advance in their pursuit of licensing that would allow them to break out into psychedelics. In essence, they’re hitting all the…
-
Interactive Games Technologies (BETS.C): The door is opening, and not just in North America
Adopting a sin as an acceptable, taxable business is slow going. From the moment our government overlords decide to un-ban a thing, it takes often years, even decades, to move through the many stages of evolution before it can become fully embraced by society. Take booze as an example. In the 1930’s, coming out of…
-
![Canntab Therapeutics (PILL.C) racks up revenue as CBD caplets shipped to Medipharm (LABS.T)]()
Canntab Therapeutics (PILL.C) racks up revenue as CBD caplets shipped to Medipharm (LABS.T)
Cannabis hard tablet IP holder Canntab Therapeutics (PILL.C) continues to send product to market, announcing Wednesday they’ve fulfilled 80% of their contract with Medipharm Labs (LABS.T), bringing in another half million dollars in revenue toward the $1.3 million deal announced last June. Orders under the agreement are a mix of Canntab’s proprietary instant release tablets…
-
Gold Mountain Mining (GMTN.V) is starting to bore me with all this effective management and kept promises
Do you ever get that feeling that you’ve written a story before? Weeks before and months before, and five times before and eight times before that? Whenever I see a Gold Mountain Mining (GMTN.V) news release come out, I get that sinking feeling in the base of my heart because I’ve got to do this…
-
Marvel Discovery (MARV.V) is a supermarket trolley full of early resource opportunities
Confused over whether you want to invest in gold explorers or battery metals? Wondering whether it’s time to get into nickel, copper, or cobalt? Do titanium, vanadium, and chromium enter your late night thoughts? Is it time for rare earths to make a run? Maybe the recent movement in uranium is your bag? If you’re…
-
Russian hackers go ham on US government agencies as Plurilock (PLUR.V) meets Homeland Security contract milestones
With US President-Elect Joe Biden having finally been, without any doubt, absolutely declared the winner of the 2020 Presidential election, Russia appears to be dropping any pretense that it’s not an enemy of the USA. With news emerging that multiple US government agencies and thousands of American businesses have been infiltrated by Russki hackers, security…
-
Delic Holdings (DELC.C) emerges as a psychedelics play aimed at executing real, legal business, and right now
Smallcap investors largely see the psychedelics space in one of two ways; you’re either in the ‘this may be big one day but there’s not a lot of fat on the bones just yet so I’ll wait’ camp, or the ‘fat schmat, everything is a trade and who cares about tomorrow’ camp. I’m pegged pretty…
-
Aequus Pharmaceuticals (AQS.V) gets Health Canada device licence approval, validates business model
Aequus Pharmaceuticals (AQS.V), a specialty pharma company with a business model of acquiring and re-platforming existing approved biotech and health products to appeal to a wider market, has announced another win Monday morning with news Health Canada has approved the advancing of their Evolve dry-eye relief gel line to an easy-squeeze eye drop bottle. Admittedly,…
